193
(B) to recommend any legislative or 
administrative changes necessary to im-
prove the effectiveness of such controls; 
and 
(3)(A) to review such Secretary’s utili-
zation of the authority granted under 
this Act to authorize an emergency use of 
a biomedical countermeasure, including 
the means by which the Secretary deter-
mines whether and under what condi-
tions any such authorizations should be 
granted and the benefits and adverse im-
pacts, if any, resulting from the use of 
such authority; and 
(B) to recommend any legislative or 
administrative changes necessary to im-
prove the utilization or effectiveness of 
such authority and to enhance protection 
of the public health. 
The results of the study shall be submitted to 
the designated congressional committees not 
later than five years after the date of the en-
actment of this Act. 
(d) REPORT REGARDING ADDITIONAL BAR-
RIERS TO PROCUREMENT OF SECURITY COUNTER-
194
MEASURES.—Not later than 180 days after the 
date of the enactment of this Act, the Sec-
retary of Homeland Security and the Sec-
retary of Health and Human Services shall re-
port to the designated congressional commit-
tees any barriers to the procurement of secu-
rity countermeasures that have not been ad-
dressed by this Act. 
(e) STATUS OF PROGRAM FOR CHEMICAL TER-
RORISM PREPAREDNESS.—Not later than 180 
days after the date of the enactment of this 
Act, the Secretary of Homeland Security shall 
submit to the designated congressional com-
mittees a report describing the status of the 
program carried out by the Secretary to en-
hance the preparedness of the United States 
to respond to terrorist attacks involving 
chemical agents. 
(f) DESIGNATED
CONGRESSIONAL
COMMIT-
TEES.—For purposes of this section, the term 
‘‘designated congressional committees’’ means 
the following committees of the Congress: 
(1) In the House of Representatives: 
the Committee on Energy and Commerce, 
the Committee on Appropriations, the
195
Committee on Government Reform, and 
the Select Committee on Homeland Secu-
rity (or any successor to the Select Com-
mittee). 
(2) In the Senate: the Committee on 
Health, Education, Labor, and Pensions, 
the Committee on Appropriations, and 
the Committee on Government Affairs. 
SEC. 6. OUTREACH. 
The Secretary of Health and Human Serv-
ices shall develop outreach measures to en-
sure to the extent practicable that diverse in-
stitutions, including Historically Black Col-
leges and Universities and those serving large 
proportions of Hispanics, Native Americans, 
Asian-Pacific Americans, or other underrep-
resented populations, are meaningfully aware 
of available research and development grants 
and procurements conducted under sections 2 
and 3 of this Act.
196
SEC. 7. ENSURING COORDINATION, COOPERATION AND 
THE ELIMINATION OF UNNECESSARY DUPLI-
CATION IN PROGRAMS DESIGNED TO PRO-
TECT THE HOMELAND FROM BIOLOGICAL, 
CHEMICAL, RADIOLOGICAL, AND NUCLEAR 
AGENTS. 
(a) 
ENSURING
COORDINATION
OF
PRO-
GRAMS.—The Secretary of Health and Human 
Services, the Secretary of Homeland Security, 
and the Secretary of Defense shall ensure the 
activities of their respective Departments co-
ordinate, complement, and do not unneces-
sarily duplicate programs to identify poten-
tial domestic threats from biological, chem-
ical, radiological or nuclear agents, detect 
such domestic incidents, analyze such inci-
dents, 
and 
develop 
necessary 
counter-
measures. The aforementioned Secretaries 
shall further ensure that information and 
technology possessed by the Departments rel-
evant to these activities are shared with the 
other Departments. 
(b) DESIGNATION OF AGENCY COORDINATION 
OFFICER.—The 
Secretary 
of 
Health 
and 
Human Services, the Secretary of Homeland 
Security, and the Secretary of Defense shall
197
each designate an officer or employee of their 
respective Departments who shall coordinate, 
through regular meetings and communica-
tions, with the other aforementioned Depart-
ments such programs and activities carried 
out by their Departments.
Union Calendar No. 98
108TH CONGRESS 
1ST SESSION 
H. R. 2122
[Report No. 108–147, Parts I, II, and III] 
A BILL 
To enhance research, development, procurement, 
and use of biomedical countermeasures to re-
spond to public health threats affecting national 
security, and for other purposes. 
JULY 8, 2003
Reported from the Select Committee on Homeland Secu-
rity with an amendment; committed to the Committee 
of the Whole House on the State of the Union and or-
dered to be printed